First Eagle Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

First Eagle Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,667	Closed	-$91K	–	168
2018 Q4	$91K	Hold	6,667	–	–	﹤0.01%	166
2018 Q3	$143K	Sell	6,667 -77,694	-92%	-$2.36M	﹤0.01%	170
2018 Q2	$3.61M	Sell	84,361 -176,339	-68%	-$8.08M	0.01%	144
2018 Q1	$17M	Sell	260,700 -33,156	-11%	-$2.35M	0.04%	118
2017 Q4	$21.4M	Buy	293,856 +16,723	+6%	+$1.38M	0.05%	125
2017 Q3	$25.4M	Buy	277,133 +5,555	+2%	+$426K	0.06%	135
2017 Q2	$18M	Buy	271,578 +16,111	+6%	+$1.99M	0.04%	141
2017 Q1	$55.4M	Buy	255,467 +18,889	+8%	+$2.7M	0.14%	98
2016 Q4	$21.9M	Sell	236,578 -6,389	-3%	-$720K	0.06%	140
2016 Q3	$32.8M	Hold	242,967	–	–	0.08%	133
2016 Q2	$24.6M	Buy	242,967 +48,000	+25%	+$5.95M	0.06%	150
2016 Q1	$31.9M	Sell	194,967 -4,277	-2%	-$867K	0.08%	136
2015 Q4	$65.3M	Sell	199,244 -9,267	-4%	-$3.02M	0.16%	115
2015 Q3	$67.3M	Buy	208,511 +17,444	+9%	+$7.66M	0.17%	113
2015 Q2	$76.1M	Buy	191,067 +32,100	+20%	+$13.6M	0.18%	106
2015 Q1	$78.3M	Buy	158,967 +2,702	+2%	+$1.05M	0.19%	103
2014 Q4	$55.9M	Buy	156,265 +16,530	+12%	+$4.92M	0.14%	117
2014 Q3	$26.9M	Sell	139,735 -5,484	-4%	-$1.21M	0.07%	149
2014 Q2	$34.7M	Buy	145,219 +16,130	+12%	+$3.28M	0.08%	139
2014 Q1	$33M	Buy	129,089 +28,516	+28%	+$8.72M	0.09%	118
2013 Q4	$19.9M	Buy	100,573 +14,089	+16%	+$2.51M	0.05%	131
2013 Q3	$14.6M	Buy	86,484 +15,200	+21%	+$2.45M	0.04%	147
2013 Q2	$12.7M	Buy	+71,284	New	+$10.1M	0.04%	164

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

First Eagle Investment Management's LUMO Position: Q1 2019 in Review

First Eagle Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2019, closing a stake of 6,667 shares — an estimated $91K sold.

First Eagle Investment Management first reported a position in LUMO in Q2 2013 and held it in 23 quarters. The position peaked at $78.3M in Q1 2015. 82 funds tracked by Wall St. Rank hold LUMO as of Q1 2019.

First Eagle Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
First Eagle Investment Management sold 6,667 Lumos Pharma, Inc. Common Stock shares in Q1 2019, an estimated $91K.
First Eagle Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 23 quarters.
First Eagle Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $78.3M in Q1 2015.
82 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2019.

Based on First Eagle Investment Management's 13F filing for Q1 2019, filed 13 May 2019.